Troy Mullane

Troy Mullane é um membro central das práticas de saúde e marketing, vendas e preços. Ele é um líder da América do Norte para lançamento de biofarma e modelo de cliente. Ele tem experiência particular em estratégia de marca; design de modelo de cliente; e valor, acesso e preços. Essa experiência também abrange uma variedade de modalidades terapêuticas, incluindo moléculas pequenas, biológicos inovadores, biossimilares e terapias celulares e genéticas. Ele também passou seis meses em 2018 destacado a uma biotecnologia, liderando o planejamento de lançamento para seu primeiro ativo comercial. 医薬品

Since joining BCG in 2011, Troy has worked with a variety of clients in the health care space, especially in biopharma where his clients range from pre-commercial biotechs to top-ten biopharma manufacturers. He has particular expertise in brand strategy; customer model design; and value, access, and pricing.

Troy’s support for biopharma clients covers strategy from product launch through commercialization and life-cycle management, across multiple disease categories including oncology, hematology, neuroscience, cardiovascular, inflammation/immunology, rare disease, and allergy. This experience also covers a range of therapeutic modalities, including small molecule, innovative biologics, biosimilars, and cell and gene therapies.

Prior to joining BCG, Troy worked for General Electric in internal audit. He also spent six months in 2018 seconded to a biotech, leading launch planning for their first commercial asset.